Form 8-K - Current report:
SEC Accession No. 0001104659-20-087039
Filing Date
2020-07-28
Accepted
2020-07-28 08:16:06
Documents
4
Period of Report
2020-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2025871d1_8k.htm 8-K 21393
2 EXHIBIT 10.1 tm2025871d1_ex10-1.htm EX-10.1 38187
3 EXHIBIT 99.1 tm2025871d1_ex99-1.htm EX-99.1 9486
4 GRAPHIC image_002.jpg GRAPHIC 8445
  Complete submission text file 0001104659-20-087039.txt   82354
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 201051818
SIC: 2834 Pharmaceutical Preparations